Fluticasone/salmeterol: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 118: Line 118:


(Description)
(Description)
|clinicalTrials=======Central Nervous System======
|clinicalTrials=======Central Nervous System======


Line 208: Line 207:
|othersTitle=Others
|othersTitle=Others
|useInOthers=(Description)
|useInOthers=(Description)
|administration=(Oral/Intravenous/etc)
|administration=(Oral/Intravenous/etc)
|monitoring======Condition 1=====
|monitoring======Condition 1=====
Line 370: Line 368:
(Description)
(Description)
|drugBox={{Drugbox2
|drugBox={{Drugbox2
| verifiedrevid =  
| type              = combo
| IUPAC_name =  
| image            = Fluticasone propionate.svg
| image =  
| image2            = Salmeterol.png
| drug_name =  
| component1        = Fluticasone
 
| class1            = [[Glucocorticoids|Glucocorticoid]]
<!--Clinical data-->
| component2        = Salmeterol
| tradename =  
| class2            = [[Beta2-adrenergic receptor agonist|Long-Acting Beta2 Agonist]]
| MedlinePlus =  
| CAS_number        =  
| licence_US =  
| ATC_prefix        =  
| pregnancy_AU =  
| ATC_suffix        =  
| pregnancy_US =  
| PubChem          =  
| legal_status =  
| DrugBank          =  
| routes_of_administration =
| pregnancy_AU      = <!-- A / B1 / B2 / B3 / C / D / X -->
 
| pregnancy_US      = <!-- A / B            / C / D / X -->
<!--Pharmacokinetic data-->
| pregnancy_category=
| bioavailability =  
| legal_AU          = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| metabolism =  
| legal_CA          = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| elimination_half-life =
| legal_UK          = P
| excretion =  
| legal_US          = <!-- OTC                  / Rx-only  / Schedule I, II, III, IV, V -->
 
| legal_status      =  
<!--Identifiers-->
| routes_of_administration = Inhaled
| CAS_number_Ref =  
| CAS_number =  
| ATC_prefix =
| ATC_suffix =
| PubChem =
| IUPHAR_ligand =
| DrugBank_Ref =
| DrugBank =
| ChemSpiderID_Ref =
| ChemSpiderID =
| UNII_Ref =
| UNII =
| KEGG_Ref =
| KEGG =
| ChEBI_Ref =
| ChEBI =
| ChEMBL_Ref =
| ChEMBL =
 
<!--Chemical data-->
| C= | H= | N= | O=  
| molecular_weight =
| smiles =
| InChI =
| InChIKey =  
| StdInChI_Ref =
| StdInChI =
| StdInChIKey_Ref =
| StdInChIKey =
| melting_point =
}}
|mechAction=(Description)
|mechAction=(Description)
|structure=(Description with picture)
|structure=(Description with picture)
Line 440: Line 407:
|howSupplied=(Description)
|howSupplied=(Description)
|fdaPatientInfo=(Patient Counseling Information)
|fdaPatientInfo=(Patient Counseling Information)
|nlmPatientInfo=(Link to patient information page)
|alcohol=Alcohol-Fluticasone/salmeterol interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
|lookAlike=* (Paired Confused Name 1a) — (Paired Confused Name 1b)
|lookAlike=* (Paired Confused Name 1a) — (Paired Confused Name 1b)
* (Paired Confused Name 2a) — (Paired Confused Name 2b)
* (Paired Confused Name 2a) — (Paired Confused Name 2b)
* (Paired Confused Name 3a) — (Paired Confused Name 3b)
* (Paired Confused Name 3a) — (Paired Confused Name 3b)
|nlmPatientInfo=(Link to patient information page)
|drugShortage=Drug Shortage
|drugShortage=Drug Shortage
}}
}}
{{Asthma_and_copd_rx}}
{{Asthma_and_copd_rx}}


Revision as of 13:30, 4 August 2014

{{DrugProjectFormSinglePage |genericName=generic name |aOrAn=a |drugClass=Adrenergic receptor agonist |indication=a list of indications, separated by commas. |hasBlackBoxWarning=Yes |adverseReactions=a list of adverse reactions, separated by commas. |blackBoxWarningTitle=Warning Title |blackBoxWarningBody=Condition Name: (Content) |fdaLIADAdult======Condition 1=====

  • Dosing Information
  • (Dosage)
Condition 2
  • Dosing Information
  • (Dosage)

|offLabelAdultGuideSupport======Condition 1=====

  • Developed by: (Organisation)
  • Class of Recommendation: (Class) (Link)
  • Strength of Evidence: (Category A/B/C) (Link)
  • Dosing Information/Recommendation
  • (Dosage)
Condition 2
  • Developed by: (Organisation)
  • Class of Recommendation: (Class) (Link)
  • Strength of Evidence: (Category A/B/C) (Link)
  • Dosing Information/Recommendation
  • (Dosage)

|offLabelAdultNoGuideSupport======Condition 1=====

  • Dosing Information
  • (Dosage)
Condition 2
  • Dosing Information
  • (Dosage)
Condition 3
  • Dosing Information
  • (Dosage)

|fdaLIADPed======Condition 1=====

  • Dosing Information
  • (Dosage)
Condition 2
  • Dosing Information
  • (Dosage)

|offLabelPedGuideSupport======Condition 1=====

  • Developed by: (Organisation)
  • Class of Recommendation: (Class) (Link)
  • Strength of Evidence: (Category A/B/C) (Link)
  • Dosing Information/Recommendation
  • (Dosage)
Condition 2
  • Developed by: (Organisation)
  • Class of Recommendation: (Class) (Link)
  • Strength of Evidence: (Category A/B/C) (Link)
  • Dosing Information/Recommendation
  • (Dosage)

|offLabelPedNoGuideSupport======Condition 1=====

  • Dosing Information
  • (Dosage)
Condition 2
  • Dosing Information
  • (Dosage)
Condition 3
  • Dosing Information
  • (Dosage)

|contraindications=* Condition 1

  • Condition 2
  • Condition 3
  • Condition 4
  • Condition 5

|warnings======Conidition 1=====

(Description) |clinicalTrials=======Central Nervous System======

(list/description of adverse reactions)
Cardiovascular
(list/description of adverse reactions)
Respiratory
(list/description of adverse reactions)
Gastrointestinal
(list/description of adverse reactions)
Hypersensitive Reactions
(list/description of adverse reactions)
Miscellaneous
(list/description of adverse reactions)
Condition 2
Central Nervous System
(list/description of adverse reactions)
Cardiovascular
(list/description of adverse reactions)
Respiratory
(list/description of adverse reactions)
Gastrointestinal
(list/description of adverse reactions)
Hypersensitive Reactions
(list/description of adverse reactions)
Miscellaneous
(list/description of adverse reactions)

|postmarketing=(Description) |drugInteractions=* Drug 1

  • Drug 2
  • Drug 3
  • Drug 4
  • Drug 5
Drug 1

(Description)

Drug 2

(Description)

Drug 3

(Description)

Drug 4

(Description)

Drug 5

(Description) |useInPregnancyFDA=(Description) |useInPregnancyAUS=(Description) |useInLaborDelivery=(Description) |useInNursing=(Description) |useInPed=(Description) |useInGeri=(Description) |useInGender=(Description) |useInRace=(Description) |useInRenalImpair=(Description) |useInHepaticImpair=(Description) |useInReproPotential=(Description) |useInImmunocomp=(Description) |othersTitle=Others |useInOthers=(Description) |administration=(Oral/Intravenous/etc) |monitoring======Condition 1=====

(Description regarding monitoring, from Warnings section)

Condition 2

(Description regarding monitoring, from Warnings section)

Condition 3

(Description regarding monitoring, from Warnings section) |IVCompat====Solution===

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

Y-Site

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

Admixture

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

Syringe

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

TPN/TNA

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

|overdose====Acute Overdose===

Signs and Symptoms

(Description)

Management

(Description)

Chronic Overdose

Signs and Symptoms

(Description)

Management

(Description) |drugBox=

Error creating thumbnail: File missing
Template:Px
Fluticasone/salmeterol
Combination of
Fluticasone Glucocorticoid
Salmeterol Long-Acting Beta2 Agonist
Identifiers
CAS number ?
ATC code ?
PubChem ?
Therapeutic considerations
Pregnancy cat.

?

Legal status

P(UK)

Routes Inhaled

Template:Asthma and copd rx

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Fluticasone/salmeterol&oldid=1006550"